Tokyo - Delayed Quote JPY
OncoTherapy Science, Inc. (4564.T)
23.00
0.00
(0.00%)
At close: 3:30:00 PM GMT+9
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
478,749
610,118
1,134,903
1,153,663
332,477
Cost of Revenue
632,528
787,836
1,093,218
1,039,751
312,935
Gross Profit
-153,779
-177,718
41,685
113,912
19,542
Operating Expense
803,378
943,081
1,148,100
2,166,549
1,657,478
Operating Income
-957,157
-1,120,799
-1,106,415
-2,052,637
-1,637,936
Net Non Operating Interest Income Expense
-17,692
-9,896
-2,332
-5,372
1,040
Pretax Income
-1,120,894
-1,285,713
-1,116,420
-2,570,306
-1,560,012
Tax Provision
2,280
2,425
2,223
1,234
1,623
Net Income Common Stockholders
-1,123,174
-1,288,138
-1,118,644
-2,571,541
-1,561,636
Diluted NI Available to Com Stockholders
-1,123,174
-1,288,138
-1,118,644
-2,571,541
-1,561,636
Basic EPS
-4.81
-6.05
-5.81
-13.72
-8.86
Diluted EPS
-4.81
-6.05
-5.81
-13.72
-8.86
Basic Average Shares
234,197.56
212,783.43
192,643.70
187,466.26
176,332
Diluted Average Shares
271,643.65
212,783.43
192,643.70
187,466.26
176,332
Total Operating Income as Reported
-957,158
-1,120,800
-1,106,415
-2,052,637
-1,637,936
Total Expenses
1,435,906
1,730,917
2,241,318
3,206,300
1,970,413
Net Income from Continuing & Discontinued Operation
-1,123,174
-1,288,138
-1,118,644
-2,571,541
-1,561,636
Normalized Income
-1,009,865.58
-1,173,445.65
-1,131,452.70
-2,188,675.34
-1,616,619.65
Interest Income
--
19
218
430
1,040
Interest Expense
764
218
0
--
--
Net Interest Income
-17,692
-9,896
-2,332
-5,372
1,040
EBIT
-1,120,130
-1,285,495
-1,116,420
-2,052,637
-1,637,936
EBITDA
-1,120,130
-1,285,495
-1,116,420
-2,036,097
-1,588,928
Reconciled Cost of Revenue
632,528
787,836
1,093,218
1,039,751
312,935
Reconciled Depreciation
--
--
0
16,540
49,008
Net Income from Continuing Operation Net Minority Interest
-1,123,174
-1,288,138
-1,118,644
-2,571,541
-1,561,636
Total Unusual Items Excluding Goodwill
-147,537
-149,339
16,678
-498,523
79,250
Total Unusual Items
-147,537
-149,339
16,678
-498,523
79,250
Normalized EBITDA
-972,593
-1,136,156
-1,133,098
-1,537,574
-1,668,178
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-34,228.58
-34,646.65
3,869.30
-115,657.34
24,266.35
3/31/2021 - 9/29/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade